Welcome to our latest podcast! Today, we’re thrilled to bring you an exclusive conversation with Lee Rodne, Executive Chairman of LTR Pharma (ASX:LTP). In this episode, Lee delves into the company’s innovative SPONTAN product, a nasal spray developed to treat erectile dysfunction quickly and effectively. We’ll discuss LTR Pharma’s vision for advancing biotech solutions, as well as the challenges and opportunities that lie ahead. Whether you're a current investor or just curious about emerging biotech innovations, this discussion offers a closer look at SPONTAN and the company’s potential future. Please remember, however, that this conversation is for informational purposes only and should not be considered financial advice. Let’s dive in!